Arcadia Biosciences Director Gregory D. Waller Receives 10,000-Share Option

What Happened
Gregory D. Waller, a director of Arcadia Biosciences, was granted a derivative award of 10,000 shares (reported as an option) on 2026-09-10. The grant is reported at $0.00 per share in the Form 4 (i.e., no cash purchase price shown). This is an awarded option/derivative (compensation), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-09-10; Form 4 filed 2026-09-14 (appears timely under the 2-business-day rule).
• Amount: 10,000 derivative shares (option award) reported at $0.00 per share.
• Vesting: The option will become 100% vested and exercisable on the earlier of (i) September 10, 2027 or (ii) the issuer’s next Annual Meeting of Stockholders, subject to Waller’s continued service.
• Shares owned after transaction: Not specified in the provided filing.
• Transaction type/code: A (grant/award of derivative securities).

Context
This grant is a time-based option award that is currently not exercisable; the holder must remain in service until the stated vesting event. Awards like this are common as director compensation and do not by themselves indicate immediate buying or selling of stock.